Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in rats

Author： Kim Juhyun   Wang Ronghua   Veverka Karen A.   Dalton James T.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.43, Iss.11, 2013-11, pp. : 993-1009

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator

By Kearbey J. D.   Wu D.   Gao W.   Miller D. D.   Dalton J. T.  

Xenobiotica, Vol. 34, Iss. 3, 2004-03 ,pp. : 273-280

Informa Healthcare

Access to resources Recommend Favorite

Disposition and metabolism of (2S,3S,4R)-N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxy methyl-2H-benzopyran-4-yl)-N'-benzylguanidine, a novel neuroprotective agent for ischemia-reperfusion damage, in rats

By Kim N. S.   Yoo H. H.   Lee M. W.   Kim H. S.   Kim D. H.  

Xenobiotica, Vol. 37, Iss. 5, 2007-05 ,pp. : 534-548

Informa Healthcare

Access to resources Recommend Favorite

Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor

By Wong H.   Chen J.Z.   Chou B.   Halladay J.S.   Kenny J.R.   La H.   Marsters J.C.   Plise E.   Rudewicz P.J.   Robarge K.   Shin Y.   Wong S.   Zhang C.   Khojasteh S.C.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 850-861

Informa Healthcare

Access to resources Recommend Favorite

Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic––pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor

By Liederer Bianca M.   Berezhkovskiy Leonid M.   Dean Brian J.   Dinkel Vikki   Peng Jing   Merchant Mark   Plise Emile G.   Wong Harvey   Liu Xingrong  

Xenobiotica, Vol. 41, Iss. 4, 2011-04 ,pp. : 327-339

Informa Healthcare

Access to resources Recommend Favorite

Urinary excretion profiles of N-hydroxy-3,4-methylenedioxymethamphetamine in rats

By Tsujikawa Kenji   Mikuma Toshiyasu   Kuwayama Kenji   Miyaguchi Hajime   Kanamori Tatsuyuki   Iwata Yuko T.   Inoue Hiroyuki  

Xenobiotica, Vol. 41, Iss. 7, 2011-07 ,pp. : 578-584

Informa Healthcare

Access to resources Recommend Favorite